Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1974 Jan;27(1):251–258. doi: 10.1128/am.27.1.251-258.1974

Interconversion of Type C and D Strains of Clostridium botulinum by Specific Bacteriophages

M W Eklund 1, F T Poysky 1
PMCID: PMC380000  PMID: 4589131

Abstract

These studies show that Clostridium botulinum types C and D cultures can be cured of their prophages and converted to either type C or D depending on the specific phage used. Strains of types C and D were cured of their prophages and simultaneously ceased to produce their dominant toxins designated as C1 and D, respectively. Cured nontoxigenic cultures derived from type C strain 162 were sensitive to the phages from the toxigenic type C strain 162 and type D strain South African. When cured nontoxigenic cultures derived from strain 162 were infected with the tox+ phages from the 162 strain of type C and the South African strain of type D, they then produced toxin neutralized by types C and D antisera, respectively. Cured nontoxigenic cultures isolated from the type D South African strain were only sensitive to the parent phage, and, when reinfected with the tox+ phage, they produced toxin neutralized by type D antiserum. Type C strain 153 and type D strain 1873, when cured of their respective prophages, also ceased to produce toxins C1 and D, but, unlike strain 162 and the South African strain, they continued to produce a toxin designated as C2. When the cured cultures from strains 153 and 1873 were infected with the tox+ phage from type D strain 1873, the cultures simultaneously produced toxin that was neutralized by type D antiserum. When these cured cultures were infected with the tox+ phage from type C strain 153, the cultures produced toxin that was neutralized by type C antiserum. These studies with the four strains of C. botulinum confirm that the toxigenicity of types C and D strains requires the continued participation of tox+ phages. Evidence is presented that types C and D cultures may arise from a common nontoxigenic strain.

Full text

PDF
255

Images in this article

256Image
on p.256
256Image
on p.256
256Image
on p.256
256Image
on p.256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARDSDALE W. L., PAPPENHEIMER A. M., Jr Phage-host relationships in nontoxigenic and toxigenic diphtheria bacilli. J Bacteriol. 1954 Feb;67(2):220–232. doi: 10.1128/jb.67.2.220-232.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLAIR J. E., CARR M. Lysogeny in staphylococci. J Bacteriol. 1961 Dec;82:984–993. doi: 10.1128/jb.82.6.984-993.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Casman E. P. Staphylococcal enterotoxin. Ann N Y Acad Sci. 1965 Jul 23;128(1):124–131. doi: 10.1111/j.1749-6632.1965.tb11634.x. [DOI] [PubMed] [Google Scholar]
  4. DUFF J. T., WRIGHT G. G., YARINSKY A. Activation of Clostridium botulinum type E toxin by trypsin. J Bacteriol. 1956 Oct;72(4):455–460. doi: 10.1128/jb.72.4.455-460.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dolman C. E., Chang E. Bacteriophages of Clostridium botulinum. Can J Microbiol. 1972 Jan;18(1):67–76. doi: 10.1139/m72-011. [DOI] [PubMed] [Google Scholar]
  6. Eklund M. W., Poysky F. T. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol. 1972 Jul;24(1):108–113. doi: 10.1128/am.24.1.108-113.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eklund M. W., Poysky F. T., Boatman E. S. Bacteriophages of Clostridium botulinum types A, B, E, and F and nontoxigenic strains resembling type E. J Virol. 1969 Feb;3(2):270–274. doi: 10.1128/jvi.3.2.270-274.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eklund M. W., Poysky F. T., Reed S. M. Bacteriophage and the toxigenicity of Clostridium botulinum type D. Nat New Biol. 1972 Jan 5;235(53):16–17. doi: 10.1038/newbio235016a0. [DOI] [PubMed] [Google Scholar]
  9. Eklund M. W., Poysky F. T., Reed S. M., Smith C. A. Bacteriophage and the toxigenicity of Clostridium botulinum type C. Science. 1971 Apr 30;172(3982):480–482. doi: 10.1126/science.172.3982.480. [DOI] [PubMed] [Google Scholar]
  10. Eklund M. W., Poysky F. T., Wieler D. I. Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States. Appl Microbiol. 1967 Nov;15(6):1316–1323. doi: 10.1128/am.15.6.1316-1323.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FREEMAN V. J. Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae. J Bacteriol. 1951 Jun;61(6):675–688. doi: 10.1128/jb.61.6.675-688.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GROMAN N. B. Evidence for the active role of bacteriophage in the conversion of nontoxigenic Corynebacterium diphtheriae to toxin production. J Bacteriol. 1955 Jan;69(1):9–15. doi: 10.1128/jb.69.1.9-15.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Inoue K., Iida H. Bacteriophages of Clostridium botulinum. J Virol. 1968 May;2(5):537–540. doi: 10.1128/jvi.2.5.537-540.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Inoue K., Iida H. Conversion of toxigenicity in Clostridium botulinum type C. Jpn J Microbiol. 1970 Jan;14(1):87–89. doi: 10.1111/j.1348-0421.1970.tb00495.x. [DOI] [PubMed] [Google Scholar]
  15. Inoue K., Iida H. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jpn J Med Sci Biol. 1971 Feb;24(1):53–56. [PubMed] [Google Scholar]
  16. Jansen B. C. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J Vet Res. 1971 Jun;38(2):93–98. [PubMed] [Google Scholar]
  17. Lee W. H., Riemann H. Correlation of toxic and non-toxic strains of Clostridium botulinum by DNA composition and homology. J Gen Microbiol. 1970 Jan;60(1):117–123. doi: 10.1099/00221287-60-1-117. [DOI] [PubMed] [Google Scholar]
  18. Segner W. P., Schmidt C. F., Boltz J. K. Enrichment, isolation, and cultural characteristics of marine strains of Clostridium botulinum type C. Appl Microbiol. 1971 Dec;22(6):1017–1024. doi: 10.1128/am.22.6.1017-1024.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vinet G., Berthiaume L., Fredette V. Un bactériophage dans une culture de Cl. botulinum C. Rev Can Biol. 1968 Mar;27(1):73–74. [PubMed] [Google Scholar]
  20. Wu J. I., Riemann H., Lee W. H. Thermal stability of the deoxyribonucleic acid hybrids between the proteolytic strains of Clostridium botulinum and Clostridium sporogenes. Can J Microbiol. 1972 Jan;18(1):97–99. doi: 10.1139/m72-016. [DOI] [PubMed] [Google Scholar]
  21. ZABRISKIE J. B. THE ROLE OF TEMPERATE BACTERIOPHAGE IN THE PRODUCTION OF ERYTHROGENIC TOXIN BY GROUP A STREPTOCOCCI. J Exp Med. 1964 May 1;119:761–780. doi: 10.1084/jem.119.5.761. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES